HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genus Pharmaceuticals Ltd.

Division of Stada Arzneimittel AG
www.genuspharma.com

Latest From Genus Pharmaceuticals Ltd.

Bronchitol Gets Final NICE OK, TOBI Podhaler Trumps Colobreathe

Pharmaxis’ Bronchitol became the first cystic fibrosis drug to get a NICE final approval, while Novartis’s TOBI Podhaler was selected ahead of Forest Lab’s Colobreathe for bacterial infection.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Stada Arzneimittel AG
  • Senior Management
  • Contact Info
  • Genus Pharmaceuticals Ltd.
    Phone: (44) 1635 568400
    Benham Valence
    Newbury, RG208LU
    UK
UsernamePublicRestriction

Register